The average tumour size of IPMN patients with KRAS mutations ranged from 2.4 to 2.9 cm, whereas the mean size of IPMNs with wild-type KRAS ranged from 2.51 to 2.86 cm. The gene discussed is KRAS; the disease is pancreatic intraductal papillary-mucinous neoplasm.